The Effect of Slow Deep Breathing Relaxation Exercise on Pain and Anxiety Levels During and Post-Chest Tube Removal After CABG.

Crit Care Nurs QAug 26, 2026 (epub)
Clinical ResearchCardiology

Ahmad Lutfi Abu Sabiha, Basma Salameh, Sameer A Alkubati et al.

✦ AI-curated · Sources linked

In 30 seconds

This randomized controlled trial evaluated the impact of slow deep breathing relaxation exercises (SDBRE) on pain and anxiety levels during and after chest tube removal in 80 patients post-coronary artery bypass grafting. The intervention group practicing SDBRE reported significantly lower pain scores during removal (5.325 vs 7.125, P < .001) and reduced anxiety levels (P < .001), indicating the effectiveness of SDBRE as a nonpharmacological intervention.

Key findings

  • Pain scores during chest tube removal were significantly lower in the SDBRE group (5.325 vs 7.125, P < .001).
  • Anxiety scores were significantly reduced during and after chest tube removal (P < .001).
  • Pain correlated with the duration of chest tube insertion and complexity of the operation.

Why it matters

The findings suggest that incorporating SDBRE into postoperative care can effectively alleviate pain and anxiety for patients undergoing chest tube removal, enhancing their overall recovery experience.

Source

PubMed · PMID 42659658

Published in Crit Care Nurs Q. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Cardiology

Clinical ResearchHematology

Ponatinib-Blinatumomab or Imatinib-Chemotherapy for Adult Ph-Positive ALL.

This multicenter, phase 3 randomized trial compared frontline ponatinib plus blinatumomab with imatinib plus chemotherapy in adults with Philadelphia-positive acute lymphoblastic leukemia.

N Engl J MedOct 15, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary
Clinical ResearchRheumatology

Ianalumab for the Treatment of Patients with Sjögren's Disease.

Two 52-week, double-blind, randomized, placebo-controlled phase III trials evaluated monthly or less frequent ianalumab in patients with active Sjögren's disease.

N Engl J MedOct 22, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text
Create my personalized digestSee plans

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.